BC-DXI-843

Overview

BC-DXI-843 is a potent and specific AIMP2-DX2 inhibitor with an IC 50 of 0.92 μM, more than 100-fold selectivity over AIMP2 (IC 50 >100 μM) in a luciferase assay. BC-DXI-843 acts as a promising lead targeting AIMP2-DX2 in lung cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Aminoacyl-tRNA Synthetase

Product Information

• Catalog No.: HY-136431
• CAS No.: 2421117-98-6
• Molecular Formula: C28H26N4O4S2
• Molecular Weight: 546.66
• Purity: 99.76%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.08 mg/mL (3.80 mM); Clear solution
• Availability: In-stock

Source

Original product source